David Martí‐Aguado

771 total citations · 2 hit papers
33 papers, 424 citations indexed

About

David Martí‐Aguado is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, David Martí‐Aguado has authored 33 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 14 papers in Hepatology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in David Martí‐Aguado's work include Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (11 papers) and Alcohol Consumption and Health Effects (7 papers). David Martí‐Aguado is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (11 papers) and Alcohol Consumption and Health Effects (7 papers). David Martí‐Aguado collaborates with scholars based in Spain, United States and Portugal. David Martí‐Aguado's co-authors include Ramón Bataller, Ana Clemente, María Pilar Ballester, Luis Martí‐Bonmatí, Desamparados Escudero‐García, Ángel Alberich‐Bayarri, Miguel A. Serra, Miguel Mínguez, Marta Maia Boscá-Watts and Clara Alfaro‐Cervelló and has published in prestigious journals such as Radiology, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

David Martí‐Aguado

30 papers receiving 418 citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cigarette smoking and liver diseases

2022 106 citations David Martí‐Aguado, Ana Clemente et al. Journal of Hepatology profile →
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease

2024 65 citations David Martí‐Aguado, Desamparados Escudero‐García et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Martí‐Aguado Spain	11	295	147	90	74	59	33	424
Hong‐Lei Ma China	13	361 1.2×	152 1.0×	37 0.4×	116 1.6×	79 1.3×	27	459
Antonio Luis Eiras de Araújo Brazil	6	403 1.4×	124 0.8×	88 1.0×	223 3.0×	87 1.5×	10	465
Clémence M. Canivet France	14	401 1.4×	190 1.3×	53 0.6×	115 1.6×	89 1.5×	37	553
Tsutomu Tamai Japan	14	269 0.9×	172 1.2×	61 0.7×	94 1.3×	61 1.0×	37	508
Yoshiko Kadokawa Japan	11	366 1.2×	218 1.5×	85 0.9×	138 1.9×	123 2.1×	21	531
Ruveena Bhavani Rajaram Malaysia	6	321 1.1×	149 1.0×	37 0.4×	137 1.9×	82 1.4×	14	458
Cameron T. Locklear United States	6	354 1.2×	221 1.5×	86 1.0×	135 1.8×	55 0.9×	7	503
Achuthan Sourianarayanane United States	13	395 1.3×	309 2.1×	42 0.5×	117 1.6×	151 2.6×	25	519
S. Francioso Italy	12	486 1.6×	245 1.7×	106 1.2×	245 3.3×	104 1.8×	24	621
Pierre M. Gholam United States	8	376 1.3×	200 1.4×	104 1.2×	177 2.4×	101 1.7×	22	505

Countries citing papers authored by David Martí‐Aguado

Since Specialization

Citations

This map shows the geographic impact of David Martí‐Aguado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Martí‐Aguado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Martí‐Aguado more than expected).

Fields of papers citing papers by David Martí‐Aguado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Martí‐Aguado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Martí‐Aguado. The network helps show where David Martí‐Aguado may publish in the future.

Co-authorship network of co-authors of David Martí‐Aguado

This figure shows the co-authorship network connecting the top 25 collaborators of David Martí‐Aguado. A scholar is included among the top collaborators of David Martí‐Aguado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Martí‐Aguado. David Martí‐Aguado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gratacós‐Ginès, Jordi, Edilmar Alvarado‐Tápias, David Martí‐Aguado, et al.. (2025). Diagnosis and Management of Early Stages of ALD. Seminars in Liver Disease. 45(2). 195–209. 2 indexed citations

Rubio‐Tomás, Teresa, David Martí‐Aguado, Delia Blaya, et al.. (2025). GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitis. JHEP Reports. 7(9). 101478–101478. 4 indexed citations

Martí‐Aguado, David, et al.. (2025). Hemostasis management optimization in patients with advanced chronic liver disease. Gastroenterología y Hepatología. 48(8). 502453–502453.

Maya‐Miles, Douglas, et al.. (2024). MASLD biomarkers: Are we facing a new era?. Gastroenterología y Hepatología. 47(4). 393–396.

Alvarado‐Tápias, Edilmar, David Martí‐Aguado, Andreu Ferrero‐Gregori, et al.. (2024). Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality. Hepatology Communications. 8(8). 5 indexed citations

Espadas, Isabel, Mario Soriano‐Navarro, Enrique Martínez‐Force, et al.. (2024). Hydroxycitrate delays early mortality in mice and promotes muscle regeneration while inducing a rich hepatic energetic status. Aging Cell. 23(9). e14205–e14205. 4 indexed citations

Martí‐Aguado, David & Luis Martí‐Bonmatí. (2023). Iron deposits in alcoholic and metabolic liver disease. 140(140(03)). 277–283. 1 indexed citations

Alvarado‐Tápias, Edilmar, David Martí‐Aguado, Kevin F. Kennedy, et al.. (2023). Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD. Obesity Surgery. 33(5). 1494–1505. 19 indexed citations

Ballester, María Pilar, et al.. (2022). Biological treatment interruption in inflammatory bowel disease: Motivation and predictive factors. Gastroenterología y Hepatología. 46(9). 671–681. 3 indexed citations

10.

Martí‐Aguado, David, Ana Clemente, & Ramón Bataller. (2022). Cigarette smoking and liver diseases. Journal of Hepatology. 77(1). 191–205. 106 indexed citations breakdown →

11.

Martí‐Aguado, David, Clara Alfaro‐Cervelló, Salvador Benlloch, et al.. (2021). Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease. Biomolecules. 11(12). 1808–1808. 12 indexed citations

12.

Martí‐Aguado, David, María Pilar Ballester, & Miguel Mínguez. (2021). Risk factors and management strategies associated with non-response to aminosalicylates for maintenance treatment in ulcerative colitis. Revista Española de Enfermedades Digestivas. 113(6). 447–453. 9 indexed citations

13.

Martí‐Aguado, David, Ana Jiménez-Pastor, Ángel Alberich‐Bayarri, et al.. (2021). Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease. Radiology. 302(2). 345–354. 34 indexed citations

14.

Jiménez-Pastor, Ana, et al.. (2021). Precise whole liver automatic segmentation and quantification of PDFF and R2* on MR images. European Radiology. 31(10). 7876–7887. 20 indexed citations

15.

Giménez‐Garzó, Carla, María Pilar Ballester, Amparo Urios, et al.. (2021). A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine. 10(13). 2806–2806. 19 indexed citations

16.

Martí‐Aguado, David, Alejandro Rodríguez, Clara Alfaro‐Cervelló, et al.. (2020). Digital pathology: accurate technique for quantitative assessment of histological features in metabolic‐associated fatty liver disease. Alimentary Pharmacology & Therapeutics. 53(1). 160–171. 27 indexed citations

17.

Martí‐Aguado, David, Alejandro Rodríguez, Ángel Alberich‐Bayarri, & Luis Martí‐Bonmatí. (2020). Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use. Abdominal Radiology. 45(11). 3557–3568. 7 indexed citations

18.

Martí‐Aguado, David, María Pilar Ballester, Joan Toscá, et al.. (2019). Long‐term follow‐up of patients treated with aminosalicylates for ulcerative colitis: Predictive factors of response: An observational case‐control study. United European Gastroenterology Journal. 7(8). 1042–1050. 14 indexed citations

19.

Ballester, María Pilar, David Martí‐Aguado, Marta Maia Boscá-Watts, et al.. (2019). Impact and risk factors of non-adherence to 5-aminosalicylates in quiescent ulcerative colitis evaluated by an electronic management system. International Journal of Colorectal Disease. 34(6). 1053–1059. 13 indexed citations

20.

Martí‐Aguado, David, María Pilar Ballester, & Marta Maia Boscá-Watts. (2017). Invasive pulmonary aspergillosis in an immunocompromised patient with severe ulcerative colitis. Revista Española de Enfermedades Digestivas. 109(4). 316–317. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact